Skip to main content
. 2018 Jun 1;24(5):666–674. doi: 10.1089/mdr.2017.0250

Table 2.

Antibacterial Activity (μg/ml) of Compounds 1–4 Against Clinical Staphylococcus aureus Pathogens

    MIC (μg/ml)  
  1 2 3 4 Vancomycin PolymyxinB Oxacillin
S. aureus BF1 4 8 8 2 2 >64 >64
S. aureus BF2 4 8 8 2 2 >64 >64
S. aureus BF3 4 8 8 2 2 >64 32
S. aureus BF4 4 8 8 2 2 >64 16
S. aureus BF5 4 8 8 2 2 >64 >64